The coronavirus known as COVID-19 first appeared in December, 2019 and spread around the world within a matter of days. As of this writing, it has infected nearly 400,000 people in 169 countries.
Scientists around the world have stopped their normal research to focus on creating a vaccine and treatment for this illness which has killed more than 17,000 people worldwide. Fortunately, more than 100,000 have recovered.
On March 22, 2020, an international team of scientists published a research paper preprint on biorXiv analyzing the interaction between the novel coronavirus and human proteins.* Their analysis predicts 332 protein-protein interactions and 69 existing pharmaceuticals that might perturb these interactions. The researchers propose that these drugs may be candidates for treating COVID-19 infections.